MorphoSys AG (MOR)
17.51
+0.10
(+0.57%)
USD |
NASDAQ |
May 01, 16:00
17.64
+0.12
(+0.71%)
Pre-Market: 09:09
MorphoSys Total Assets (Quarterly): 2.240B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.240B |
| June 30, 2023 | 2.328B |
| March 31, 2023 | 2.431B |
| December 31, 2022 | 2.570B |
| June 30, 2022 | 2.620B |
| March 31, 2022 | 2.743B |
| December 31, 2021 | 2.894B |
| September 30, 2021 | 3.345B |
| March 31, 2021 | 1.934B |
| December 31, 2020 | 2.041B |
| September 30, 2020 | 1.620B |
| June 30, 2020 | 1.602B |
| March 31, 2020 | 1.473B |
| December 31, 2019 | 556.10M |
| September 30, 2019 | 592.07M |
| June 30, 2019 | 633.07M |
| March 31, 2019 | 624.73M |
| December 31, 2018 | 616.29M |
| September 30, 2018 | 672.45M |
| June 30, 2018 | 633.32M |
| March 31, 2018 | 483.48M |
| December 31, 2017 | 498.35M |
| September 30, 2017 | 495.14M |
| June 30, 2017 | 515.97M |
| March 31, 2017 | 485.04M |
| Date | Value |
|---|---|
| December 31, 2016 | 490.10M |
| September 30, 2016 | 420.27M |
| June 30, 2016 | 423.35M |
| March 31, 2016 | 443.75M |
| December 31, 2015 | 437.41M |
| September 30, 2015 | 475.36M |
| June 30, 2015 | 481.59M |
| March 31, 2015 | 467.00M |
| December 31, 2014 | 518.61M |
| September 30, 2014 | 550.80M |
| June 30, 2014 | 592.40M |
| March 31, 2014 | 600.92M |
| December 31, 2013 | 618.16M |
| September 30, 2013 | 615.89M |
| June 30, 2013 | 321.11M |
| March 31, 2013 | 298.37M |
| December 31, 2012 | 296.62M |
| September 30, 2012 | 290.40M |
| June 30, 2012 | 278.50M |
| March 31, 2012 | 303.05M |
| December 31, 2011 | 295.86M |
| September 30, 2011 | 325.51M |
| June 30, 2011 | 345.44M |
| March 31, 2011 | 348.31M |
| December 31, 2010 | 279.02M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
556.10M
Minimum
Dec 2019
3.345B
Maximum
Sep 2021
1.976B
Average
2.141B
Median
Total Assets (Quarterly) Benchmarks
| Incyte Corp | 7.136B |
| Novartis AG | 94.33B |
| Immatics NV | 563.72M |
| Affimed NV | 107.40M |
| InflaRx NV | 132.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.186B |
| Shareholders Equity (Quarterly) | 54.22M |
| Debt to Equity Ratio | 12.71 |
| Current Ratio | 3.080 |
| Net Debt Paydown Yield | -9.26% |